Top Markets
Coin of the day
IGEA Pharma N.V. IGEA Pharma N.V.

IGEA Pharma N.V.

IGPH
Rank in Stocks #40705
IGEA Pharma N.V. specializes in marketing health and medical technology... IGEA Pharma N.V. specializes in marketing health and medical technology products and devices across the United States and the Netherlands. Its product portfolio features Alz1, a home-based diagnostic kit for measuring non-bound copper in the bloodstream, alongside Alz1 Tab dietary supplements formulated to decrease heavy metal levels in the blood. The company also offers a rapid test for COVID-19, which identifies IgM and IgG SARS-CoV-2 antibodies. Additionally, it provides dry aerosol generators for sanitizing air and inanimate surfaces, as well as equipment for air purification and sterilization. The company also performs laboratory analysis services. Founded in 2015, IGEA Pharma N.V. maintains its primary offices in Hoofddorp, the Netherlands.
Share Price
$0.00057292
Last synced: 2023-12-04
Market Cap
$95.08K
Change (1 day)
0.59%
Change (1 year)
0.00%
Country
NL
Trade IGEA Pharma N.V. (IGPH)

Category

Operating Margin for IGEA Pharma N.V. (IGPH)
Operating Margin as of 2026 TTM: 0.00%
According to IGEA Pharma N.V. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for IGEA Pharma N.V. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.69% -
US
20.42% -
US
0.00% -
CN
-12.97% -
US
31.63% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.